Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease.
D000368:Aged; D001971:Bromocriptine / Q000009:adverse effects*; D003221:Confusion / Q000139:chemically induced; D003863:Depression / Q000150:complications; D004873:Ergolines / Q000009:adverse effects*; D005260:Female; D006212:Hallucinations / Q000150:complications; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000139:chemically induced*; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000139:chemically induced; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*; D012563:Schizophrenia, Paranoid / Q000139:chemically induced
D004873:Ergolines; D001971:Bromocriptine